{"DataElement":{"publicId":"3123693","version":"1","preferredName":"Fixed Tissue Paraffin Blocks Availability Indicator","preferredDefinition":"Text indicator to signify whether formalin-fixed paraffin-embedded tissue is available.","longName":"3123691v1.0:3123685v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3123691","version":"1","preferredName":"Fixed Tissue Paraffin Blocks","preferredDefinition":"Agents employed in the preparation of histologic or pathologic specimens for the purpose of maintaining the existing form and structure of all of the constituent elements._information relating to paraffin tissue blocks._Agents employed in the preparation of histologic or pathologic specimens for the purpose of maintaining the existing form and structure of all of the constituent elements._","longName":"FIX_TISS_PARFF_BLOCK","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3123689","version":"1","preferredName":"Fixative Tissue","preferredDefinition":"Agents employed in the preparation of histologic or pathologic specimens for the purpose of maintaining the existing form and structure of all of the constituent elements.:An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","longName":"C498:C12801","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fixative","conceptCode":"C498","definition":"A compound that preserves tissues and cells for microscopic study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tissue","conceptCode":"C12801","definition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BC362B5-1879-F621-E040-BB89AD4317C0","latestVersionIndicator":"Yes","beginDate":"2010-07-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-19","modifiedBy":"ONEDATA","dateModified":"2010-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207711","version":"1","preferredName":"Paraffin Blocks","preferredDefinition":"Paraffin is a common name for a group of high molecular weight alkane hydrocarbons with the general formula CnH2n+2, where n is between 22 and 27. Paraffin is also a technical name for an alkane in general, but in most cases it refers specifically to a linear, or normal alkane. It is mostly found as a white, odorless, tasteless, waxy solid, with a melting point between 47C and 65C. It is insoluble in water, but soluble in ether, benzene, and certain esters. Paraffin is unaffected by most common chemical reagents but oxidizes readily. (from Wikipedia):Blocks; refers to preserved specimens embedded in support material.","longName":"C727:C25436","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Paraffin","conceptCode":"C727","definition":"A common name for a group of high molecular weight alkane hydrocarbons with the general formula CnH2n+2, where n is between 22 and 27. Paraffin is also a technical name for an alkane in general, but in most cases it refers specifically to a linear, or normal alkane. It is mostly found as a white, odorless, tasteless, waxy solid, with a melting point between 47C and 65C. It is insoluble in water, but soluble in ether, benzene, and certain esters. Paraffin is unaffected by most common chemical reagents but oxidizes readily.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fixed Block","conceptCode":"C25436","definition":"Refers to preserved specimens embedded in support material.  These are typically cut into thin slices for microscopic examination, with or without an enhancement such as staining.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2D66-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BC362B5-1887-F621-E040-BB89AD4317C0","latestVersionIndicator":"Yes","beginDate":"2010-07-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3123685","version":"1","preferredName":"Tissue Availability Indicator","preferredDefinition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function._The quality of being obtainable or accessible and ready for use or service._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"3123685v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"7","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"2560453","version":"1","preferredName":"Yes","longName":"2560453","preferredDefinition":"The affirmative response to a question or activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B932-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CLOHNES","dateModified":"2023-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BC1C923-9E0E-5F51-E040-BB89AD4331F6","beginDate":"2010-07-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-19","modifiedBy":"ONEDATA","dateModified":"2010-07-19","deletedIndicator":"No"},{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"2559515","version":"1","preferredName":"No","longName":"2559515","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B588-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BC1C923-9E18-5F51-E040-BB89AD4331F6","beginDate":"2010-07-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-19","modifiedBy":"ONEDATA","dateModified":"2010-07-19","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2960664","version":"1","preferredName":"Unknown","longName":"2960664","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78485FBD-4C65-D67B-E040-BB89AD432E0E","latestVersionIndicator":"Yes","beginDate":"2009-11-13","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-11-13","modifiedBy":"KUMMEROA","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BC1C923-9E22-5F51-E040-BB89AD4331F6","beginDate":"2010-07-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-19","modifiedBy":"ONEDATA","dateModified":"2010-07-19","deletedIndicator":"No"},{"value":"NA","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"3261243","version":"1","preferredName":"Not Applicable","longName":"3261243","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA2BBD66-6581-A6F2-E040-BB89AD4311D3","latestVersionIndicator":"Yes","beginDate":"2011-08-10","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-08-10","modifiedBy":"RAGUNATHANU","dateModified":"2024-02-05","changeDescription":"12/15/15 added N/A as alternate VM-tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"32A7AF68-DA04-FDF9-E050-BB89AD4332A0","beginDate":"2016-05-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-05-12","modifiedBy":"ONEDATA","dateModified":"2016-05-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3123684","version":"1","preferredName":"Tissue Availability Indicator","preferredDefinition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.:Available; obtainable or accessible and ready for use or service.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"C12801:C25429:C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tissue","conceptCode":"C12801","definition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Availability","conceptCode":"C25429","definition":"The quality of being obtainable or accessible and ready for use or service.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BC1C923-9DE8-5F51-E040-BB89AD4331F6","latestVersionIndicator":"Yes","beginDate":"2010-07-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-19","modifiedBy":"ONEDATA","dateModified":"2010-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BC1C923-9DF9-5F51-E040-BB89AD4331F6","latestVersionIndicator":"Yes","beginDate":"2010-07-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-19","modifiedBy":"SBR","dateModified":"2016-10-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"3528035","version":"1","longName":"Docosahexaenoic Acid","context":"DCP"}]},{"publicId":"3124057","version":"1","longName":"Sarcoma Database","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3124058","version":"1","longName":"Sarcoma Database CDEs","context":"NCIP"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"4188651","version":"1","longName":"MDA2013-01-02","context":"DCP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104880","version":"1","longName":"GOG-0221","context":"NRG"},{"publicId":"10000276","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"4104930","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"10000275","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"4104892","version":"1","longName":"GOG-0229O","context":"NRG"}]},{"publicId":"4254096","version":"1","longName":"Protocol Phase","context":"PBTC","ClassificationSchemeItems":[{"publicId":"10000103","version":"1","longName":"Phase I","context":"PBTC"},{"publicId":"4254119","version":"1","longName":"PBTC-042","context":"PBTC"}]}],"AlternateNames":[{"name":"DCP","type":"USED_BY","context":"DCP"},{"name":"F_TS_PAR_B_AVAIL_IND","type":"DCP Alt Name","context":"DCP"},{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"GOG","type":"USED_BY","context":"NRG"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"3123691v1.0:3123685v1.0","type":"USED_BY","context":"NRG"},{"name":"CCTG","type":"USED_BY","context":"CCTG"}],"ReferenceDocuments":[{"name":"Is there formalin-fixed paraf","type":"Preferred Question Text","description":"Is there formalin-fixed paraffin-embedded tissue available?","url":null,"context":"NCIP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Does the patient have a block or 25 unstained sections of formalin-fixed and paraffin-embedded primary tumor available to satisfy the primary tumor requirement specified in Section 7.2?","url":null,"context":"CTEP"},{"name":"Specimen is Formalin-fixed and Paraffin Embedded","type":"Alternate Question Text","description":"Specimen is Formalin-fixed and Paraffin Embedded","url":null,"context":"DCP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Does the patient have formalin-fixed, paraffin-embedded (FFPE) primary, metastatic, or recurrent tumor tissue for molecular analysis?","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Does the patient have formalin-fixed, paraffin-embedded tumor tissue for CLIA-certified KRAS mutation testing?","url":null,"context":"NRG"},{"name":"NRG_CRF Text","type":"Alternate Question Text","description":"Will five unstained formalin-fixed, paraffin-embedded (FFPE) tumor tissue slides be submitted for determination of BAF250a immunohistochemistry (IHC) status?","url":null,"context":"NRG"},{"name":"DCP Text 1","type":"Alternate Question Text","description":"Was residual specimen paraffin-embedded?","url":null,"context":"DCP"},{"name":"PBTC_Text1","type":"Alternate Question Text","description":"Does the patient have formalin-fixed, paraffin-embedded (FFPE) tumor tissue for Rb1 testing?","url":null,"context":"PBTC"},{"name":"PBTC_Text2","type":"Alternate Question Text","description":"Does patient with HGG have sufficient tumor material for planned biology studies?","url":null,"context":"PBTC"},{"name":"PBTC_Text3","type":"Alternate Question Text","description":"Does patient with HGG enrolled on Stratum B have sufficient tumor material for planned biology studies?","url":null,"context":"PBTC"},{"name":"PBTC_Text4","type":"Alternate Question Text","description":"Does the patient have sufficient tumor material as specified in the protocol for the planned biology studies?","url":null,"context":"PBTC"},{"name":"PBTC_Test5","type":"Alternate Question Text","description":"Does the patient have formalin-fixed, paraffin-embedded (FFPE) tumor tissue for Rb1 testing if not previously tested in a CLIA certified laboratory?","url":null,"context":"PBTC"},{"name":"CRF Text 5","type":"Alternate Question Text","description":"Is the formalin-fixed, paraffin-embedded tumor tissue from the biopsy or curettage available for submission?","url":null,"context":"NRG"},{"name":"PBTC_Text6","type":"Alternate Question Text","description":"Does patient have sufficient tumor material for planned biology studies (optional for DIPG patient)?","url":null,"context":"PBTC"},{"name":"CCTG - 1","type":"Alternate Question Text","description":"Is tumour tissue available and able to be released for this patient, so that the specific and protocol-mandated correlative marker assays may be conducted?","url":null,"context":"CCTG"},{"name":"PBTC_Text7","type":"Alternate Question Text","description":"Does the patient have sufficient tumor tissue for MET activation confirmation using FDA approved panel if a MET aberration is identified using local test in a CLIA certified laboratory?","url":null,"context":"PBTC"},{"name":"PBTC_Text8","type":"Alternate Question Text","description":"Does the patient have sufficient pre-trial tumor tissue available for subgrouping?","url":null,"context":"PBTC"},{"name":"PBTC_Text9","type":"Alternate Question Text","description":"Does the patient have formalin-fixed, paraffin-embedded (FFPE) tumor tissue for B7H3 (CD276) testing if not previously tested in a CLIA certified laboratory?","url":null,"context":"PBTC"},{"name":"PBTC_Text10","type":"Alternate Question Text","description":"If MET aberration has been identified using local test in a CLIA certified lab, does the patient have sufficient tumor tissue for MET activation confirmation using an FDA approved panel?","url":null,"context":"PBTC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BC362B5-1898-F621-E040-BB89AD4317C0","latestVersionIndicator":"Yes","beginDate":"2010-07-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-19","modifiedBy":"RICHARDS","dateModified":"2022-03-24","changeDescription":"Curated for the Sarcoma Database","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}